If the researchers have a suspicion that the new intervention is working far better than the control (trial being extended), don't they have a moral obligation to shut the trial down now and give the patients on the control drug the opportunity to have the new intervention? Does anyone know?
Add to My Watchlist
What is My Watchlist?